(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.34%) $79.22
(-1.03%) $2.01
(0.03%) $2 310.20
(0.21%) $26.89
(0.51%) $967.50
(-0.07%) $0.932
(-0.16%) $10.97
(-0.16%) $0.797
(1.51%) $92.51
-15.24% $ 23.70
Live Chart Being Loaded With Signals
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis...
Stats | |
---|---|
Dzisiejszy wolumen | 24 198.00 |
Średni wolumen | 69 432.00 |
Kapitalizacja rynkowa | 57.66M |
EPS | $0 ( 2024-03-11 ) |
Następna data zysków | ( $0 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.44 |
ATR14 | $0.256 (1.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-13 | Phillips Anne M. | Buy | 0 | |
2024-03-05 | Baker Bros. Advisors Lp | Buy | 52 925 | Prefunded Warrants |
2024-03-05 | Baker Bros. Advisors Lp | Buy | 4 780 | Prefunded Warrants |
2024-03-05 | Baker Bros. Advisors Lp | Sell | 52 881 | Common Stock |
2024-03-05 | Baker Bros. Advisors Lp | Sell | 4 776 | Common Stock |
INSIDER POWER |
---|
60.91 |
Last 83 transactions |
Buy: 13 416 272 | Sell: 2 785 487 |
vTv Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
SIFY | 0.816 |
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
vTv Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-90 000.00 (0.00 %) |
EPS: | $-9.71 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-90 000.00 (0.00 %) |
EPS: | $-9.71 |
FY | 2022 |
Przychody: | $2.02M |
Zysk brutto: | $1.93M (95.44 %) |
EPS: | $-13.39 |
FY | 2021 |
Przychody: | $4 005.00 |
Zysk brutto: | $4 005.00 (100.00 %) |
EPS: | $-0.000276 |
Financial Reports:
No articles found.
vTv Therapeutics Inc
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule GLP-1 receptor agonist for postprandial glucose excursion to treat cystic fibrosis related diabetes; HPP3033, a non-electrophilic therapeutic approach to activating the Nrf2 pathway for the treatment of chronic diseases associated with oxidative stress; azeliragon, a RAGE antagonist for inflammatory lung diseases, including severe COVID-19, as well as for pancreatic and breast cancers; and HPP971, an Nrf2 activator for renal diseases through partnerships with pharmaceutical partners. The company has a license agreement with Reneo Pharmaceuticals, Inc. to develop and commercialize peroxisome proliferation activated receptor delta agonist program, including the compound HPP593. vTv Therapeutics Inc. also has license and research agreements with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.; Newsoara Biopharma Co., Ltd.; JDRF International; and Novo Nordisk A/S. The company was incorporated in 2015 and is headquartered in High Point, North Carolina. vTv Therapeutics Inc. is a subsidiary of MacAndrews & Forbes Incorporated.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej